Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01861028 · ClinicalTrials.gov registry record
Study Comparing Fit of the iTotal Versus Standard Total Knee Implants
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 44
- Enrollment target
NCT01861028: Clinical Trial study, sponsored by Restor3D.
NCT01861028 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01861028 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study compares intraoperative fit of the patient-specific iTotal knee replacement to other standard knee replacement implants
Primary Outcome
Fit will be measured in 4 quadrants on the tibia using a ruler to measure the distance between the customized implant and the edge of the tibia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-12 |
Why NCT01861028 stopped before completion
NCT01861028 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01861028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01861028 about?
NCT01861028 is a clinical study titled "Study Comparing Fit of the iTotal Versus Standard Total Knee Implants". This study compares intraoperative fit of the patient-specific iTotal knee replacement to other standard knee replacement implants
What is the current status of trial NCT01861028?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2013-02. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01861028?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia